StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.96−0.16 (-3.88%)

Close on Nov 17, 2026Market cap $317.61MP/E –Yield –

Atea Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Atea Pharmaceuticals's price to sales ratio was 1.4× on Apr 29, 2022.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 20221.4×–

More Atea Pharmaceuticals figures

See a number that looks wrong?